Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cellerix SA

Division of TiGenix NV
www.cellerix.com

Latest From Albany Molecular Research Inc.

Deal Watch: Novartis Signs Deals In Migraine & Diabetes

Novartis will invest in the Calgary-based Parvus and collaborate on a Navacim candidate for type 1 diabetes. Japan's Sawai moves into the US market by acquiring Upsher-Smith's generics business, while Denovo acquires a suspended depression candidate from AMRI for its personalized development approach.

Deals M & A

People Briefs

EnteroMedics appoints president and CEO; former Medtronic chair elected to Halyard Health Board of Directors; T2 Biosystems names chief commercial officer; AngioDynamics CFO transition; new Merit Medical Systems CFO tapped.

Medical Device Business Strategies

Execs On The Move, November 2015

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

AMRI adds API with Gadea

Spain
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Spain
  • Parent & Subsidiaries
  • TiGenix NV
  • Senior Management
  • Eduardo Bravo, CEO
    Claudia D'Augusta, PhD, CFO
    Jose Luis Bravo, MD, PhD, VP, Global Medical, R&D
  • Contact Info
  • Cellerix SA
    Phone: (34) 91 804 92 64
    Calle Marconi, 1
    Tres Cantos
    Madrid, 28760
    Spain
Advertisement
Advertisement
UsernamePublicRestriction

Register